serine has been researched along with charybdotoxin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, J; Dattani, ID; Desai, KM; Gopalakrishnan, V; Mishra, RC; Quest, D; Tripathy, S | 1 |
| Akhtar, J; Balsevich, J; Desai, KM; Gandhi, JD; Gopalakrishnan, V; Mishra, RC; Tripathy, S | 1 |
| Han, LY; Jiang, R; Jiang, ZL; Qiang, R; Ren, TJ; Sun, L; Wang, GH; Zhao, GW | 1 |
3 other study(ies) available for serine and charybdotoxin
| Article | Year |
|---|---|
L-Serine lowers while glycine increases blood pressure in chronic L-NAME-treated and spontaneously hypertensive rats.
Topics: Animals; Apamin; Blood Pressure; Charybdotoxin; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glycine; Heart Rate; Hypertension; Male; NG-Nitroarginine Methyl Ester; Potassium Channels, Calcium-Activated; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Serine; Threonine | 2008 |
Decreases in splanchnic vascular resistance contribute to hypotensive effects of L-serine in hypertensive rats.
Topics: Animals; Apamin; Blood Pressure; Cardiac Output; Charybdotoxin; Disease Models, Animal; Hypertension; Hypotension; Male; Potassium Channels, Calcium-Activated; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regional Blood Flow; Serine; Splanchnic Circulation; Spleen; Vascular Resistance | 2010 |
Improvement in regional CBF by L-serine contributes to its neuroprotective effect in rats after focal cerebral ischemia.
Topics: Animals; Apamin; Cerebrovascular Circulation; Charybdotoxin; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Potassium Channels, Calcium-Activated; Rats; Rats, Sprague-Dawley; Serine; Time Factors | 2013 |